The present invention discloses a pharmaceutical topical compositioncomprising cannabidiol(CBD) or a derivative thereof and Tetrahydrocannabinol (THC) or a derivativethereof in an about1:1 ratio, useful for treatment or prevention of inflammatory skin disorders,and treatment methodsthereof.